Tag archive for ‘Perrigo Company’
Jewish Business News On Wednesday, June 15th, 2016

UK company to acquire Perrigo for $20 billion

  The pharmaceutical company’s share price is up 9.1% on the TASE after reports that an unnamed UK company will acquire it for $20 billion. Streetinsider.com said yestarday that the US drugmaker More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
News Brief On Thursday, November 12th, 2015

Mylan-targeted Perrigo held merger talks with Endo -sources

Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International Plc in an all-stock deal, according More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Gali Raz On Friday, October 30th, 2015

U.S. Court Denies Perrigo’s Attempt to Block Mylan’s Takeover Bid

Mylan N.V., which made a hostile takeover bid for Perrigo Co., said Friday that a U.S. District court denied Perrigo’s attempt to block the potential closing of Mylan’s proposed offer before shareholders. The More...

Shiri Habib-Valdhorn On Thursday, August 13th, 2015

Mylan might make do with only 50% of Perrigo

  Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that More...

Niva Goldberg On Sunday, July 26th, 2015

Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ

Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...

Niva Goldberg On Thursday, July 23rd, 2015

Three ways takeover battle: Mylan invokes “poison pill” to block Teva hostile takeover

  Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the Call Option Agreement, dated April 3, 2015, between More...

Three Way Takeover Battle: Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced on Friday that it has completed the purchase of a 4.61% More...

Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Teva’s Mylan stake up to 4.3%

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) continues to accumulate shares in takeover target Mylan (MYL), even as Mylan’s largest shareholder, Abbott Labs (NYSE: ABT), announced More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Mylan to list on TASE if Perrigo bid succeeds

  One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company’s acquisition by Mylan More...

Shiri Habib-Valdhorn On Monday, June 15th, 2015

Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding

  Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...

Wordpress site Developed by Fixing WordPress Problems